HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naomi S Taus Selected Research

Malignant Catarrh

7/2016Replacement of Glycoprotein B in Alcelaphine Herpesvirus 1 by Its Ovine Herpesvirus 2 Homolog : Implications in Vaccine Development for Sheep-Associated Malignant Catarrhal Fever.
2/2015Antibodies to ovine herpesvirus 2 glycoproteins decrease virus infectivity and prevent malignant catarrhal fever in rabbits.
1/2015Cross-Reactivity of Neutralizing Antibodies among Malignant Catarrhal Fever Viruses.
8/2014Malignant catarrhal fever in American bison (Bison bison) experimentally infected with alcelaphine herpesvirus 2.
10/2013Fibroblasts express OvHV-2 capsid protein in vasculitis lesions of American bison (Bison bison) with experimental sheep-associated malignant catarrhal fever.
6/2013Goats are a potential reservoir for the herpesvirus (MCFV-WTD), causing malignant catarrhal fever in deer.
8/2009Development of a multiplex real-time PCR for detection and differentiation of malignant catarrhal fever viruses in clinical samples.
9/2008Development of a management program for a mixed species wildlife park following an occurrence of malignant catarrhal fever.
3/2008Detection of ovine herpesvirus 2 major capsid gene transcripts as an indicator of virus replication in shedding sheep and clinically affected animals.
2/2006Sheep-associated malignant catarrhal fever virus: prospects for vaccine development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naomi S Taus Research Topics

Disease

11Infections
01/2022 - 08/2006
10Malignant Catarrh
07/2016 - 02/2006
5Babesiosis (Piroplasmosis)
12/2021 - 08/2018
1Vector Borne Diseases
12/2021
1Vasculitis (Vasculitides)
10/2013
1Herpes Simplex
05/2002

Drug/Important Bio-Agent (IBA)

7VaccinesIBA
08/2021 - 02/2006
3Biological ProductsIBA
08/2021 - 01/2019
3Glycoproteins (Glycoprotein)IBA
01/2018 - 02/2015
3Capsid Proteins (Capsid Protein)IBA
10/2013 - 03/2008
3DNA (Deoxyribonucleic Acid)IBA
06/2013 - 07/2008
2AntigensIBA
12/2021 - 01/2018
2AntibodiesIBA
12/2021 - 02/2015
2EnzymesIBA
01/2018 - 09/2008
2ImmunosorbentsIBA
01/2018 - 09/2008
2Viral DNAIBA
06/2013 - 05/2002
2Indicators and Reagents (Reagents)IBA
07/2008 - 03/2008
2AerosolsIBA
07/2008 - 08/2006
1Polysaccharides (Glycans)IBA
01/2022
1RNA (Ribonucleic Acid)IBA
12/2020
1vitellogenin receptorIBA
01/2019
1Recombinant ProteinsIBA
01/2018
1Neutralizing AntibodiesIBA
01/2015
1EpitopesIBA
08/2014
1Proteins (Proteins, Gene)FDA Link
10/2013
1Complement System Proteins (Complement)IBA
03/2013
1Fluorescent Dyes (Fluorescent Probes)IBA
08/2009
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2008

Therapy/Procedure

1Intraperitoneal Injections
07/2008